Annual report
5194.TEDINET S100OIXY
Period2021-04-01 → 2022-03-31
Filed2022-06-28
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥5.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥5.6bn | 2020-04-01 → 2021-03-31 | Cons. | Net sales |
| Revenue | ¥6.6bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥6.3bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.9bn | 2017-04-01 → 2018-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.1bn | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Operating income | ¥1.2bn | 2020-04-01 → 2021-03-31 | Cons. | Operating income |
| Ordinary income | ¥1.5bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.0bn | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.3bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥917m | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.8bn | 2017-04-01 → 2018-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.5bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥987m | 2020-04-01 → 2021-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.1bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥598m | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥902m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥553m | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.3bn | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.1bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Net income | ¥586m | 2020-04-01 → 2021-03-31 | Cons. | Profit loss |
| Total assets | ¥17.0bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥15.7bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥16.1bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥14.1bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥15.2bn | at 2018-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥8.1bn | at 2022-03-31 | Cons. | Liabilities |
| Total liabilities | ¥8.1bn | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥8.9bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥7.6bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥7.2bn | at 2020-03-31d | Cons. | Net assets |
| Net assets / equity | ¥6.5bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥6.3bn | at 2018-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.5bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.5bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.5bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥2.9bn | at 2018-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥905m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.4bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥981m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥793m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥676m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.2bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥608m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.0bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.5bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥190m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥671m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥86m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥165m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.7bn | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥101.1 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.08 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥83.1 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥50.94 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥120.44 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥797.34 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥675.55 | at 2021-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥640 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥577.19 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥552.98 | at 2018-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 50.8% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.7% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.1% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.3% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.4% | at 2018-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 13.7% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.4% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.7% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.0% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 24.6% | 2017-04-01 → 2018-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 796 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 871 | at 2021-03-31 | Cons. | Number of employees |
| Employees | 862 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 850 | at 2019-03-31d | Cons. | Number of employees |
| Employees | 798 | at 2018-03-31d | Cons. | Number of employees |
| Revenue | ¥5.8bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥5.5bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥8.2bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥6.2bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥7.9bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.0bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | ¥1.2bn | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥1.1bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.2bn | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.6bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.2bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.4bn | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.0bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.2bn | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥690m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥770m | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | ¥1.1bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥817m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥901m | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥15.9bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥16.4bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥16.6bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥13.6bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥14.8bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥6.1bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥7.2bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥9.8bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥9.2bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥8.5bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥7.6bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥7.0bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥824m | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥734m | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥63.58 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥70.95 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥98.66 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥75.28 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥82.92 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥10 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2020-04-01 → 2021-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2017-04-01 → 2018-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥905.27 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥851.12 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥781.9 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥699.51 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥643.1 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 61.7% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.3% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.1% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.0% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.0% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 7.2% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.7% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.3% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.2% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.7% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 10,937,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,937,000 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,937,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,937,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,937,000 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 207 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 207 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 212 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 210 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 208 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 76
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2021-04-01 → 2022-03-31 | ¥704,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2021-04-01 → 2022-03-31 | ¥10m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2022-03-31 | 40 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2022-03-31 | ¥214m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2022-03-31 | ¥214m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2022-03-31 | ¥236m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2022-03-31 | −¥72m |
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥3m |
| Reconciling Itemsreconciling | depreciation | 2021-04-01 → 2022-03-31 | ¥10m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥1.3bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥343m |
| Health Care Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥767m |
| Health Care Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥464m |
| Health Care Businessreportable segment | employees | at 2022-03-31 | 679 pure |
| Health Care Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥4.0bn |
| Health Care Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥4.0bn |
| Health Care Businessreportable segment | segment assets | at 2022-03-31 | ¥14.5bn |
| Health Care Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥1.5bn |
| Plastic Products Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥10m |
| Plastic Products Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥14m |
| Plastic Products Businessreportable segment | employees | at 2022-03-31 | 56 pure |
| Plastic Products Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.2bn |
| Plastic Products Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.2bn |
| Plastic Products Businessreportable segment | segment assets | at 2022-03-31 | ¥943m |
| Plastic Products Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥45m |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥777m |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥478m |
| —segment total | employees | at 2022-03-31 | 735 pure |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥5.2bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥5.2bn |
| —segment total | segment assets | at 2022-03-31 | ¥15.5bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥778m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥487m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥5.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥5.4bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥15.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥1.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2020-04-01 → 2021-03-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2020-04-01 → 2021-03-31 | ¥12m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2020-04-01 → 2021-03-31 | ¥204m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2020-04-01 → 2021-03-31 | ¥204m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2021-03-31 | ¥243m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2020-04-01 → 2021-03-31 | −¥93m |
| Reconciling Itemsreconciling | capex | 2020-04-01 → 2021-03-31 | ¥24m |
| Reconciling Itemsreconciling | depreciation | 2020-04-01 → 2021-03-31 | ¥10m |
| Reconciling Itemsreconciling | segment assets | at 2021-03-31 | ¥1.2bn |
| Reconciling Itemsreconciling | segment profit | 2020-04-01 → 2021-03-31 | −¥333m |
| Health Care Businessreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥653m |
| Health Care Businessreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥388m |
| Health Care Businessreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥4.2bn |
| Health Care Businessreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥4.2bn |
| Health Care Businessreportable segment | segment assets | at 2021-03-31 | ¥13.3bn |
| Health Care Businessreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥1.5bn |
| Plastic Products Businessreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥6m |
| Plastic Products Businessreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥17m |
| Plastic Products Businessreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥1.2bn |
| Plastic Products Businessreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥1.2bn |
| Plastic Products Businessreportable segment | segment assets | at 2021-03-31 | ¥918m |
| Plastic Products Businessreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥94m |
| —segment total | capex | 2020-04-01 → 2021-03-31 | ¥659m |
| —segment total | depreciation | 2020-04-01 → 2021-03-31 | ¥405m |
| —segment total | revenue | 2020-04-01 → 2021-03-31 | ¥5.4bn |
| —segment total | revenue external | 2020-04-01 → 2021-03-31 | ¥5.4bn |
| —segment total | segment assets | at 2021-03-31 | ¥14.3bn |
| —segment total | segment profit | 2020-04-01 → 2021-03-31 | ¥1.6bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-04-01 → 2021-03-31 | ¥663m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-04-01 → 2021-03-31 | ¥417m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-04-01 → 2021-03-31 | ¥5.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-04-01 → 2021-03-31 | ¥5.6bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-03-31 | ¥14.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-04-01 → 2021-03-31 | ¥1.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2022-03-31 | 38 pure |
| Health Care Businessreportable segment | employees | at 2022-03-31 | 92 pure |
| Plastic Products Businessreportable segment | employees | at 2022-03-31 | 56 pure |
| —segment total | employees | at 2022-03-31 | 148 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,531
| Item | Context | Value | Unit |
|---|---|---|---|
| Proceeds from sales of property plant and equipment inv cf | Prior1YearDuration | 209000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | CurrentYearDuration | 26000 | JPY |
| Purchase of investment securities inv cf | Prior1YearDuration | -1279000 | JPY |
| Purchase of investment securities inv cf | CurrentYearDuration | -1295000 | JPY |
| Purchase of intangible assets inv cf | Prior1YearDuration | -12095000 | JPY |
| Purchase of intangible assets inv cf | CurrentYearDuration | -1765000 | JPY |
| Payments of loans receivable inv cf | Prior1YearDuration | -4100000 | JPY |
| Payments of loans receivable inv cf | CurrentYearDuration | － | JPY |
| Collection of loans receivable inv cf | Prior1YearDuration | 2194000 | JPY |
| Collection of loans receivable inv cf | CurrentYearDuration | 520000 | JPY |
| Net cash provided by used in investment activities | Prior1YearDuration | -2162673000 | JPY |
| Net cash provided by used in investment activities | CurrentYearDuration | -675759000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YearDuration | 456720000 | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYearDuration | 502352000 | JPY |
| Proceeds from long term loans payable fin cf | Prior1YearDuration | 1400000000 | JPY |
| Proceeds from long term loans payable fin cf | CurrentYearDuration | 530200000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YearDuration | -1073980000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYearDuration | -1112311000 | JPY |
| Purchase of treasury stock fin cf | Prior1YearDuration | -143000 | JPY |
| Purchase of treasury stock fin cf | CurrentYearDuration | -423000 | JPY |
| Cash dividends paid fin cf | Prior1YearDuration | -110128000 | JPY |
| Cash dividends paid fin cf | CurrentYearDuration | -108363000 | JPY |
| Other net fin cf | Prior1YearDuration | -1234000 | JPY |
| Other net fin cf | CurrentYearDuration | -1350000 | JPY |
| Net cash provided by used in financing activities | Prior1YearDuration | 671232000 | JPY |
| Net cash provided by used in financing activities | CurrentYearDuration | -189896000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YearDuration | -5644000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYearDuration | 17137000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YearDuration | -90442000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYearDuration | 56797000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 1565022000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 1474580000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 1474580000 | JPY |
| Cash and cash equivalents | CurrentYearInstant | 1531378000 | JPY |
| Number of consolidated subsidiaries | CurrentYearInstant | 3 | |
| Number of unconsolidated subsidiaries and associates accounted for using equity method | CurrentYearInstant | 1 | |
| Merchandise and finished goods | Prior1YearInstant | 479174000 | JPY |
| Merchandise and finished goods | CurrentYearInstant | 462641000 | JPY |
| Work in process | Prior1YearInstant | 394321000 | JPY |
| Work in process | CurrentYearInstant | 661964000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 697391000 | JPY |
| Raw materials and supplies | CurrentYearInstant | 806452000 | JPY |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period | Prior1YearDuration | 63895000 | JPY |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period | CurrentYearDuration | 80800000 | JPY |
| Write downs of inventories | Prior1YearDuration | -8124000 | JPY |
| Write downs of inventories | CurrentYearDuration | -2104000 | JPY |
| Sales commission sga | Prior1YearDuration | 19891000 | JPY |
| Sales commission sga | CurrentYearDuration | 19891000 | JPY |
| Salaries allowances and bonuses sga | Prior1YearDuration | 349534000 | JPY |
| Salaries allowances and bonuses sga | CurrentYearDuration | 356326000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |